Martindale Pharma

Information

Name

Martindale Pharma

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

Address

Bampton Road, Harold Hill

Romford
RM3 8UG
United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Martindale Pharma
Sign up free

Contracts awarded to Martindale Pharma

The contracts that Martindale Pharma have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 1 month ago

NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products

Project title: NHS National Framework for the supply of Generics Housekeeping Products & Oral Products, commencing 1 June 2025 Offer reference number: CM/PHG/24/5720 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/24/5720/01 - Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months) NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months) LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months) CM/PHG/24/5720/02 - Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months) DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months) DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

£11,656,086 Bids close: 3 months ago
Award

Published 1 month ago

NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025

Project title: NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025 Offer reference number: CM/PHG/24/5720 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/24/5720/01 – Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months) NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months) LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months) CM/PHG/24/5720/02 – Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months) DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months) DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

£36
Award

Published 1 month ago

NP35925 Cardiovascular & Respiratory Medicines

This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

£82,305,880
Award

Published 3 months ago

NP39724 Generic and Biosimilar Cancer Medicines

Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.

£10,396,962
Award

Published 5 months ago

NHS National Generic Pharmaceuticals Wave 15a

NHS National Generic Pharmaceuticals - Wave 15a. Offer reference number: CM/PHG/23/5697. Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5697/01 – Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months) CM/PHG/23/5697/02 – Hospital Only Products: DNW & DLN: 01/02/2025 to 31/01/2027 (24 months) CM/PHG/23/5697/03 – Hospital Only Products (Housekeeping): DLS & DNE: 01/02/2025 to 31/05/2026 (16 months) DCE & DSW: 01/02/2025 to 30/09/2025 (8 months)

£170
Award

Published 8 months ago

ENT, Ophthalmology & Skin Medicines/Medical Devices

Supply of ENT, Ophthalmology & Skin Medicines/Medical Devices to NHS Scotland.

£10,838,512

Contacts

+44 7891785953

Statistics (1 Year)

Contracts Won

Total Won

£31,961,315

Average Win

£10,653,772

Martindale Pharma

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Martindale Pharma

NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products

NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025

NP35925 Cardiovascular & Respiratory Medicines

NP39724 Generic and Biosimilar Cancer Medicines

NHS National Generic Pharmaceuticals Wave 15a

ENT, Ophthalmology & Skin Medicines/Medical Devices

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win